Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 2562 Posts
1 2 3 ... 161
The Top 11 Big Pharma Dividend Stocks Ranked By Total Return
Article By: SureDividend
Monday, July 16, 2018 8:04 PM EDT
Drug companies are often considered defensive in nature due to their stable earnings, through good economies and bad.
In this article: LLY, MRK, AZN, BMY, AMGN, GILD, PFE, ABBV, GSK, NVS, SNY
Read
Johnson & Johnson Looks To Be In Trouble Amid Lawsuits
Article By: Leigh Drogen
Monday, July 16, 2018 3:48 PM EDT
Johnson & Johnson will release its FQ2’18 earnings report tomorrow, July 17th. Johnson & Johnson has recently been hit by a wave of various victim lawsuits.
In this article: JNJ
Read
The Market Gypsy That Lives By Her Own Rules
Article By: Michele Schneider
Saturday, July 14, 2018 6:19 PM EDT
Beginning with Nasdaq, or the most crowded index populated with the fewest prime choices, the week ended on new all-time highs. S&P, also crowded, ended well, just shy of the 2018 high 280.41 made in March. The Dow got back over 250—our terror zone.
In this article: IBB, QQQ, IWM, IYT, KRE, SMH, SPY, XRT
Read
Week In Review: Tasly Biopharma Completes Pre-IPO Round At $1.9 Billion Valuation
Article By: ChinaBio® Today
Saturday, July 14, 2018 4:49 PM EDT
Tasly Biopharma (SHA: 600535) of Shanghai raised $84.5 million in new capital from a group of investors that included Ally Bridge. The funding is a pre-IPO round as Tasly is planning to list on the Hong Kong Exchange.
In this article: MRK, NVS, IBIO
Read
What Investors Need To Know About Biotech ETFs
Video By: Neena Mishra
Friday, July 13, 2018 6:50 AM EDT
The biotech sector has performed better than the broader healthcare space this year. And within the biotech sector, smaller companies have done much better than their larger counterparts.
In this video: IBB, FBT, XBI
Watch
3 Gene Therapy Stocks Investors Can Bet On In Rest Of 2018
Article By: Zacks Investment Research
Friday, July 13, 2018 3:05 AM EDT
Innovation holds the key in the pharma/biotech sector and most companies have been diverting their resources to develop gene therapy candidates in their goal of finding a cure for difficult and incurable diseases.
In this article: BOLD, QURE, AXON Also: NVS, PFE, SLDB
Read
Acceleron Downgraded To Neutral From Overweight At Piper Jaffray
Article By: The Fly
Tuesday, July 10, 2018 7:19 AM EDT
Piper Jaffray analyst Edward Tenthoff downgraded Acceleron Pharma to Neutral and lowered his price target for the shares to $52 from $55.
In this article: XLRN Also: CELG
Read
Biotech Rally Buffeted By Trump Tweet But Gains Hold
Article By: Rod Raynovich
Tuesday, July 10, 2018 1:00 AM EDT
The Biogen catalyzed rally has stalled on another tweet on drug pricing from POTUS.
In this article: PFE, IBB, AMGN, BIIB, CELG, GILD, XLV, XPH, ABBV
Read
Why Biotech Stocks Rallied On Biogen's Alzheimer's Test
Article By: Zacks Investment Research
Sunday, July 8, 2018 5:48 PM EDT
Several major biotech stocks rallied on Friday after Biogen BIIB reported positive results from a Phase 2 study of its Ban2401 therapy, which seeks to reduce toxic amyloid proteins associated with cognitive decline and Alzheimer’s disease.
In this article: ESALY, IBB, AMGN, BIIB, CELG, GILD
Read
Biotechnology Stocks Preparing A New Bullish Trend
Article By: Taki Tsaklanos
Sunday, July 8, 2018 11:26 AM EDT
Biotechnology stocks look bullish, and even more bullish than ever in the last three years.
In this article: IBB, ILMN, REGN, BIIB, CELG, XBI, ARRY, FOLD, SGMO, XLRN
Read
Week In Review: Suzhou Innovent Files For HK IPO -- $500 Million Raise Rumored
Article By: ChinaBio® Today
Saturday, July 7, 2018 4:06 PM EDT
Innovent Biologics of Suzhou has filed to IPO on the Hong Kong Exchange under its new rules for pre-revenue biopharmas. The company plans to raise as much as $500 million, according to media reports, at a valuation of over $1 billion.
In this article: LLY, SNY, SVA, BABA, ATNX
Read
A Higher Calling: How Israeli Marijuana Research Changed The World
Article By: Avi Jorisch
Friday, July 6, 2018 11:43 PM EDT
As much of the world debates how to address marijuana use, an Israeli scientist is the first to isolate, analyze and synthesize the major psychoactive and non-psychoactive compounds in cannabis and developed a number of treatments.
Read
Is Pfizer (PFE) A Great Stock For Value Investors?
Article By: Zacks Investment Research
Thursday, July 5, 2018 2:14 AM EDT
Value investing a popular way to find great stocks in any market environment. Who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
In this article: PFE
Read
Inability To Control Emotions: That's Why 90% Of You Lose Money
Article By: Gary Savage
Sunday, July 1, 2018 4:08 PM EDT
While there are literally thousands of ways to make money in the market, I think the most dependable way to make sustainable long term gains is to be a contrarian.
Read
10 Hot Small Caps Primed For A Winning Streak (Part I)
Article By: TipRanks
Sunday, July 1, 2018 10:11 AM EDT
Despite market jitters, there is one group of stocks that continue to outperform. That’s small caps. Indeed, year-to-date the Russell 2000 small cap index is up 7%. This is versus the S&P 500 which is up only 1.67%.
In this article: GTN, MTW, HIIQ, PRMW, QURE
Read
5 Top Performing Stocks Of The Best ETF Of 1H2018
Article By: Sweta Killa
Saturday, June 30, 2018 6:20 PM EDT
PowerShares S&P SmallCap Healthcare Fund PSCH​ topped the list of best performing equity ETFs of the first half of 2018, with impressive returns of about 30.6%. The rally was mainly driven by tax reform, rising M&A and positive regulatory backdrop.
In this article: PSCH, TCMD, RGNX, ENTA, TRHC, SRDX
Read
1 to 16 of 2562 Posts
1 2 3 ... 161